Riley Bove

MD

Neurologist

About me

Dr. Riley Bove is a neurologist who provides comprehensive care for patients with multiple sclerosis, including women who are pregnant or going through menopause.

Bove's research is dedicated to finding new ways to promote neurological recovery in people with MS, including through emerging technologies and hormonal modulation. She has written more than 25 articles on the role that hormones, such as estrogens and testosterone, play in regulating the course of MS and other neurological disorders. She has also written and lectured on the importance of comprehensively targeting the health needs of men with MS.

Bove also studies how technologies such as telemedicine can improve the abilities of people with MS to obtain medical care, regain function and participate in research.

Bove received her medical degree from Harvard Medical School. She then completed a residency in the joint neurology program of Massachusetts General and Brigham and Women's hospitals, followed by a clinical research fellowship at the Partners Multiple Sclerosis Center. Bove also earned a master's degree through Harvard Medical School's clinical investigation program.

After graduating from Harvard with a bachelor's degree in anthropology, Bove took several years to travel the world on a Fulbright grant, learning from patients and families through ethnographic study and film work.

Bove is a member of the American Academy of Neurology and Consortium of Multiple Sclerosis Centers. She speaks French, Spanish and some Portuguese.

  • Education

    Harvard School of Medicine, 2007

  • Residencies

    Massachusetts General Hospital and Brigham and Women's Hospital, Neurology , 2011

  • Fellowship

    Partners Multiple Sclerosis Center, Brigham and Women's Hospital , Clinical Research , 2015

  • Academic Title

    Assistant Professor

  • Languages

    French

    Portuguese

    Spanish

I am committed to improving the lives of patients with neurological conditions in California and abroad.

Multiple Sclerosis Center

1500 Owens St., Suite 320
San Francisco, CA 94158

Decorative Caduceus

Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis

The primary goal of this study is to assess the efficacy of bazedoxifene (BZA) as remyelinating agent in patients with relapsing-remitting multiple sclerosis (RRMS). The investigators will utilize electrophysiologi...

Recruiting

Decorative Caduceus

Melatonin for Sleep in MS

Many people with MS report sleep disturbances. However, objective data on sleep quality in MS, such as those obtained using actigraphy, remain scant, as do data about optimal therapeutic management. Melatonin is freq...

Recruiting

Decorative Caduceus

Computerized Cognitive Training in MS

WHO: 40 participants with a confirmed diagnosis of Multiple Sclerosis (MS) able to engage in moderate physical activity. WHY: The purpose of this study is to evaluate two computerized brain training tools, which ...

Recruiting

Share